• Blog
  • Reviews
  • Contact US
    Sign in Sign up
    • Psychiatry Education Forum Academy
    • PEFA Network
    • Blog
    • Reviews
    • Dashboard
    • Contact Us

    Tag: MDD

    MDD Augmentation: Low Dose Naltrexone

    We finish our lecture series “10 Augmentation Strategies for MDD” with our tenth (and last) lecture on the role of Low Dose Naltrexone as an…

    Dr. Harvinder Singh January 29, 2023

    MDD Augmentation: S-Adenosyl Methionine (SAMe)

    We continue our lecture series “10 Augmentation Strategies for MDD” with our ninth lecture on the role of SAMe as an augmentation for major depressive…

    Dr. Harvinder Singh January 28, 2023

    MDD Augmentation: Pramipexole

    We continue our lecture series “10 Augmentation Strategies for MDD” with our eighth lecture on the role of Pramipexole as an augmentation for major depressive…

    Dr. Harvinder Singh January 26, 2023

    MDD Augmentation: Stimulants

    We continue our lecture series “10 Augmentation Strategies for MDD” with our sixth lecture on the role of Stimulants as an augmentation for major depressive…

    Dr. Harvinder Singh January 22, 2023

    MDD Augmentation: Lamotrigine

    We continue our lecture series “10 Augmentation Strategies for MDD” with our fifth lecture on the role of Lamotrigine as an augmentation for major depressive…

    Dr. Harvinder Singh January 21, 2023

    MDD Augmentation: L-MethylFolate

    We continue our lecture series “10 Augmentation Strategies for MDD” with our fourth lecture on the role of L-MethylFolate as an augmentation for major depressive…

    Dr. Harvinder Singh January 19, 2023

    MDD Augmentation: Thyroid Hormone

    We continue our lecture series “10 Augmentation Strategies for MDD” with our third lecture on the role of thyroid hormine as an augmentation for major…

    Dr. Harvinder Singh January 15, 2023

    MDD Augmentation: Lithium

    We continue our lecture series “10 Augmentation Strategies for MDD” with our second lecture on the role of lithium as an augmentation for major depressive…

    Dr. Harvinder Singh January 15, 2023

    MDD Augmentation: Atypical Antipsychotics

    It is known that close to 50% of patients with major depressive episodes may not achieve remission after the trials of first-line antidepressants, and only…

    Dr. Harvinder Singh January 13, 2023

    Cariprazine: New FDA Indication for MDD Augmentation

    On Dec 16, 2022: AbbVie announced that FDA has approved Cariprazine as an adjunctive therapy to antidepressants for the treatment of major depressive disorder in…

    Dr. Harvinder Singh December 18, 2022

    Augmentation Strategies for Major Depressive Disorder

    PSYCHIATRY EDUCATION FORUM ACADEMY’S LECTURE SERIES: MAJOR DEPRESSIVE DISORDER: 10 AUGMENTATION STRATEGIES Introduction Psychiatry Education Forum Academy continues to provide high-quality, evidence-based & practice-oriented discussions…

    Dr. Harvinder Singh December 17, 2022

    Single-Dose Psilocybin for a Treatment-Resistant Depression?

    Psychiatry Education Forum Academy is excited to announce the release of Academy’s 19th Journal Club discussion today: This article was published in the NEJM on…

    Dr. Harvinder Singh November 5, 2022

    Managing Treatment Resistant Depression with Atypical Features

    Depression with atypical features is defined as significant mood reactivity combined with two of the following clinical features: Hyperphagia Hypersomnia Leaden paralysis Pathological rejection sensitivity…

    Dr. Harvinder Singh September 14, 2022

    Can St. John’s Wort help with Depression?

    Psychiatry Education Forum Academy is excited to announce our next presentation’s release date for Sep 10, 2022: WATCH INTRODUCTION VIDEO https://youtu.be/Q01KwQTdTqM There are many plant-based…

    Dr. Harvinder Singh September 5, 2022

    Auvelity: New Oral Fast Acting FDA Approved Antidepressant

    On Aug 19, 2022 Axsome Therapeutics announced the FDA Approval of Auvelity, as the first and Only Oral NMDA Receptor Antagonist for the treatment of…

    Dr. Harvinder Singh August 22, 2022

    Omega-3 Fatty Acids for Depression?

    Recently Omega-3 polyunsaturated fatty acids, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) have drawn the clinical attention for the treatment of major depressive disorder. The…

    Dr. Harvinder Singh May 31, 2022

    Managing Severe Melancholic Depression

    Melancholic features in major depressive disorder are characterized by: ONE of the following present during the most severe period of the current episode: Loss of…

    Dr. Harvinder Singh April 2, 2022

    How Long to Continue Antidepressants for MDD Treatment?

    Once you have initiated antidepressants for MDD (Major Depressive Disorder) treatment and the patient has achieved remission, how long will you continue this current antidepressant…

    Dr. Harvinder Singh November 1, 2021

    Treatment-Resistant MDD: Modafinil Augmentation

    Partial response, no response, or residual symptoms following antidepressant therapy is common in clinical psychiatry. Hence, it is of clinical importance to have knowledge of…

    Dr. Harvinder Singh September 21, 2021

    Journal Club #2: Omega-3 Fatty Acids for MDD Treatment (ISNPR Practice Guidelines)

    Today we posted the following second journal club in PEFA Journal Club’s discussion series: Journal Club #2: International Society for Nutritional Psychiatry Research Practice Guidelines…

    Dr. Harvinder Singh June 14, 2021

    Journal Club #1: Update on Nonpsychotic Unipolar Depression Management

    We begin PEFA Journal Club’s updated schedule with our first journal club discussion today: Journal Club #1: The Psychopharmacology Algorithm Project at the Harvard South…

    Dr. Harvinder Singh June 13, 2021

    Medications vs Psychotherapy for MDD: Comparing 5 Major Guidelines

    How do you decide between psychotherapy versus medications for the treatment of major depressive disorder? Depression severity is one of the criteria used to make…

    Dr. Harvinder Singh May 8, 2021

    Join Academy Membership

    Most Recent Posts

    • Anti-NMDAR Encephalitis: What should you know as a Psychiatrist? March 9, 2023
    • Transdermal Asenapine March 5, 2023
    • Managing Bipolar Disorder in Elderly February 25, 2023
    • Serotonin Syndrome February 19, 2023
    • Antipsychotics Induced Nocturnal Enuresis February 18, 2023
    • Psycho-Ophthalmology: Psychotropics Ocular Adverse Events February 11, 2023
    • Integrative and Complementary Psychiatry February 5, 2023
    • Hydroxychloroquine & Psychotropics Interaction February 3, 2023
    • Amazon RxPass: $5/month Generics January 30, 2023
    • MDD Augmentation: Low Dose Naltrexone January 29, 2023
    • MDD Augmentation: S-Adenosyl Methionine (SAMe) January 28, 2023
    • MDD Augmentation: Pramipexole January 26, 2023
    • MDD Augmentation: Buspirone January 22, 2023

    Please note that this website is for educational purposes only and do refer to sources cited at the end of each topics for more information. Psychiatry Education Forum and authors do not assume any liability or responsibility for damage, injury, or death to you, other persons or property from any use of any ideas, information, or instruction in this website.

    Psychiatry Education Forum
    © 2023 - Psychiatry Education Forum   DISCLAIMER: Please note that this website is for educational purposes only and do refer to sources cited at the end of each topic for more information. Psychiatry Education Forum and authors do not assume any liability or responsibility for damage, injury, or death to you, other persons, or property from any use of any ideas, information, or instruction in this website.

    Report

    There was a problem reporting this post.

    Harassment or bullying behavior
    Contains mature or sensitive content
    Contains misleading or false information
    Contains abusive or derogatory content
    Contains spam, fake content or potential malware

    Block Member?

    Please confirm you want to block this member.

    You will no longer be able to:

    • See blocked member's posts
    • Mention this member in posts
    • Invite this member to groups
    • Message this member
    • Add this member as a connection

    Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

    Report

    You have already reported this .